To Pre-Sub or Not to Pre-Sub? Weighing the Value of the FDA’s Pre-Submission Program
January 7, 2020
By J. Lawrence Stevens, RAC and principal consultant, One Way Consultants
The U.S. Food and Drug Administration’s Pre-Submission program was created to with the intent of lowering medical device companies’ submission times. Gain some valuable insights about how the program can help you get clearance for your device and increase speed to market.
Full story